Fundraising Fox

Kalderos

Acquired

Chicago, US · Founded 2019 · Delaware corporation · 62 employees on LinkedIn · 5 known investors

Kalderos describes its company culture, values, and diversity and inclusion initiatives, including a women-in-tech program.

Also known as Kalderos, Inc.

Founders & leadership

Kalderos was founded in 2019 by Jeremy Docken.

JD
Jeremy DockenChief Executive Officer of Issuer
JS
Jim SparksExecutive
RHRusty Hensley
Rusty HensleyinChief Legal and Administrative Officer
AFAngie Franks
Angie FranksinChief Executive Officer
ML
Micah LitowNamed on SEC filing

Board

CS
Clint StoneBoard director
RPRobyn Peters
Robyn PetersinIndependent Board Director2024–2026Operating Partner at Valspring Capital
YCYumin Choi
Yumin Choiin𝕏Board directorCo-Founder & Managing Partner at Valspring Capital
JKJoe Kaiser
Joe Kaiserin𝕏Board Member2019–2026Senior Investment Advisor at Mercato Partners
WS
William SarrailleBoard director

Investors · 5

Reported raises · per SEC filings

Form D private placements

$76.3M disclosed across 4 rounds · 2019–2024

$26.4MraisedJan 2025 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim SparksExecutive Officer
  • Clint StoneDirector
  • William SarrailleDirector
  • Robyn PetersDirector
  • Rusty HensleyExecutive Officer
  • Angie FranksExecutive Officer, Director
  • Yumin ChoiDirector
  • Joe KaiserDirector
Offering amount
$29.3M
Amount sold
$26.4M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$14.9MraisedSep 2022 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brent DoverExecutive Officer, Director, Promoter
  • Micah LitowExecutive Officer, Director
  • Aaron SymanskiDirector
  • Joe KaiserDirector
  • Jeremy DockenExecutive Officer, Director
  • Yumin ChoiDirector
Offering amount
$20M
Amount sold
$14.9M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$28MraisedJun 2020 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeremy DockenExecutive Officer, Director
  • Joe KaiserDirector
  • Yumin ChoiDirector
  • Aaron SymanskiDirector
  • Micah LitowDirector
Offering amount
$28M
Amount sold
$28M
First sale
May 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$7MraisedMay 2019 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joe KaiserDirector
  • Jeremy DockenExecutive Officer, Director
  • Micah LitowDirector
Offering amount
$7M
Amount sold
$7M
Minimum investment
$250K
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Kalderos is a healthcare technology company that built what it describes as the first platform for Drug Discount Management, aimed at detecting, disputing and preventing noncompliant drug discounts across the U.S. drug discount ecosystem. The platform aggregates drug discount data in the cloud and applies AI and machine learning to identify claims that may involve misapplied discounts, particularly duplicate discounts between the 340B program and Medicaid.

The company organizes its offering into three product suites. For drug manufacturers it provides MDRP Discount Monitoring (identifying and disputing noncompliant Medicaid discounts), Commercial Discount Monitoring (transparency around commercial rebates) and Truzo (prevention of noncompliant discounts). For covered entities it provides Discount Hub, which digitizes the 340B good faith inquiry process and enables direct communication with manufacturers and states. For state Medicaid agencies it provides state dispute reports so states can work with multiple manufacturers on disputes and address data integrity issues. The company also publishes commentary on regulatory topics such as the Inflation Reduction Act's Maximum Fair Price and 340B.

Business model

Kalderos sells software to participants in the drug discount ecosystem, with distinct product suites for drug manufacturers, covered entities (such as 340B program coordinators and community health centers) and state Medicaid payers, delivered as a cloud platform with sales and customer support functions.

Traction

The company reports more than 4,250 covered entities on its platform, more than 850,000 claims reviewed across Medicaid and commercial channels, more than $1 billion in noncompliance identified, and covered entity responses to inquiries originating from all 50 U.S. states.

Latest developments

Kalderos announced on its website that it has been acquired by Model N and is now part of that company, which provides end-to-end commercialization, optimization and compliance software for life sciences companies. The company continued to list open engineering and data roles, including senior data engineer, senior software engineer and manager of data engineering.

Full profile — market position, technology, go-to-market, geography

Market position

Positions itself as the creator of the first Drug Discount Management platform and as a neutral intermediary connecting manufacturers, covered entities and state payers, and following its acquisition operates as part of Model N's life sciences commercialization and compliance platform.

Technology

A cloud-based Drug Discount Management platform that consolidates large volumes of drug discount data and applies AI and machine learning to surface high-risk claims, strengthen compliance checks, identify 340B/Medicaid duplicate discount requests and support dispute resolution workflows.

Go-to-market

Direct sales motion ("talk to sales" and general inquiry channels) targeting manufacturers, covered entities and states, supported by content marketing through a blog, resource library, FAQ, press kit and newsletter, plus a customer help center and phone/email support.

Drug manufacturers (including midsize biopharma government pricing teams), 340B covered entities such as community health centers and 340B program coordinators, and state Medicaid offices and pharmacy directors.

Geography

United States, with offices in Boston (33 Arch Street) and Chicago (625 W Adams Street); covered entities in all 50 U.S. states have responded to inquiries on the platform.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Claims reviewed across Medicaid and commercialJan 2025850,000 claims
Covered entities on the Kalderos platformJan 20254,250 covered entities
HeadcountAug 202662
Noncompliance identifiedJan 2025$1B
US states in which covered entities have responded to inquiriesJan 202550 states

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 1

by search overlap

Companies competing with Kalderos for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 1

launches, deals, and filings
Jan 2025
Kalderos acquired by Model N

Kalderos states on its website that it has been acquired by Model N, a commercialization, optimization and compliance platform for life sciences companies, and is now part of Model N.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Legal entities · 1

corporate structure
KalderosDelaware

In the news

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Kalderos do?
Kalderos operates a cloud Drug Discount Management platform for manufacturers, covered entities and state Medicaid payers.
Who founded Kalderos?
Kalderos was founded by Jeremy Docken in 2019.
Who are Kalderos's investors?
Kalderos's investors include Bascom Ventures, Mercato Partners, Savano Capital Partners, Valspring Capital, Bain Capital Ventures.
How much funding has Kalderos raised?
Kalderos has disclosed $76.3M raised across 4 rounds.
Where is Kalderos headquartered?
Kalderos is headquartered in Chicago, US.